These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18023027)

  • 1. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
    Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
    Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the genetic susceptibility for cholangiocarcinoma in primary sclerosing cholangitis.
    Lazaridis KN
    Hepatology; 2008 Jan; 47(1):8-10. PubMed ID: 18161699
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
    Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
    Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
    Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
    Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of cholangiocarcinoma associated NKG2D polymorphisms in colorectal carcinoma.
    Melum E; Buch S; Schafmayer C; Kalthoff H; Tepel J; Schreiber S; Karlsen TH; Hampe J
    Int J Cancer; 2008 Jul; 123(1):241-2. PubMed ID: 18398827
    [No Abstract]   [Full Text] [Related]  

  • 8. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
    Margalit M; Elinav H; Goldin E; Ilan Y
    Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
    Wiencke K; Spurkland A; Schrumpf E; Boberg KM
    Hepatology; 2001 Oct; 34(4 Pt 1):625-30. PubMed ID: 11584356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
    Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
    Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma.
    Wadsworth CA; Dixon PH; Taylor-Robinson S; Kim JU; Zabron AA; Wong JH; Chapman MH; McKay SC; Spalding DR; Wasan HS; Pereira SP; Thomas HC; Whittaker JC; Williamson C; Khan SA
    J Clin Exp Hepatol; 2019; 9(2):171-175. PubMed ID: 31024198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
    J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of MICA Gene Polymorphism in Opisthorchis viverrini-Induced Periductal Fibrosis in Northeastern Thais.
    Myo Oo TZ; Saichua P; Phoksawat W; Sithithaworn P; Mairiang E; Sripa B; Leelayuwat C; Jumnaisong A
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3213-3219. PubMed ID: 37774074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma.
    Chaiteerakij R; Juran BD; Aboelsoud MM; Harmsen WS; Moser CD; Giama NH; Allotey LK; Mettler TA; Baichoo E; Zhang X; Therneau TM; Lazaridis KN; Roberts LR
    Cancer Med; 2015 Oct; 4(10):1599-602. PubMed ID: 26276523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
    J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of primary sclerosing cholangitis.
    Björnsson E
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYH rs3219476 and rs3219472 polymorphisms and risk of cholangiocarcinoma.
    You SH; Wang X; Huang S; Wang M; Ji GZ; Xia JR; Fan ZN
    Mol Med Rep; 2013 Jan; 7(1):347-51. PubMed ID: 23138270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.